A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.

Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.

In the retrospective validation cohort of 205 patients with PD-L1-High mNSCLC without actionable mutations, patients classified as Onclara IO High had a median overall survival of 484 days, compared ...

When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment decisions, and finding the appropriate treatment has allowed him to maintain his ...

WASHINGTON (AP) - Certain current or former heavy smokers should start getting yearly scans for lung cancer to cut their risk of death from the nation's top cancer killer, government advisers said ...

A 75-year-old man with poorly differentiated adenocarcinoma in the right lower lobe received neoadjuvant carboplatin, paclitaxel, and nivolumab therapy. Although posttreatment CT scans suggested ...

In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy ...

Computed tomography (CT) examinations (known more commonly as a “CT scan” or “CAT scan”) incorporate a series of x-ray images taken of areas inside the body and use a computer to create a ...

Cancer is often difficult to detect in its early stages. Biomarkers that can reveal the disease are present only in very small amounts in the blood. As a result, many tests today require additional ...

About 40% of cancers among Americans can be attributed to potentially modifiable factors such as smoking, drinking, obesity, and physical inactivity. If a widely reported study from earlier this year ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...